{
    "id": 18689,
    "fullName": "CIP2A over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CIP2A over exp indicates an over expression of the Cip2a protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 57650,
        "geneSymbol": "CIP2A",
        "terms": [
            "CIP2A",
            "KIAA1524",
            "p90"
        ]
    },
    "variant": "over exp",
    "createDate": "02/25/2016",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4753,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colorectal cancer cells overexpressing Cip2a demonstrated a decrease in Cip2a levels, reduced cell proliferation, and impairment of cell growth when treated with Gilenya (fingolimod) (PMID: 24448818).",
            "molecularProfile": {
                "id": 19043,
                "profileName": "CIP2A over exp"
            },
            "therapy": {
                "id": 3610,
                "therapyName": "Fingolimod",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4696,
                    "pubMedId": 24448818,
                    "title": "PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24448818"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 19043,
            "profileName": "CIP2A over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}